Cardiotoxicity Monitoring of Pyrotinib in Combination with Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in HER2-positive Breast Cancer: a Single-Armed Clinical Trial.
Gland Surgery（2022）
Key words
Cardiotoxicity,pyrotinib,HER2-positive breast cancer,chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined